Passage Bio Stock Price

0.22 (10.84%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 440,309
Bid Price 2.12
Ask Price 2.25
News -
Day High 2.25


52 Week Range


Day Low 2.03
Company Name Stock Ticker Symbol Market Type
Passage Bio Inc PASG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.22 10.84% 2.25 19:33:53
Open Price Low Price High Price Close Price Prev Close
2.03 2.03 2.25 2.12 2.03
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,369 440,309 $ 2.18 $ 957,782 - 1.57 - 12.42
Last Trade Time Type Quantity Stock Price Currency
18:25:04 1 $ 2.25 USD


Draw Mode:

Passage Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 122.54M 54.46M 42.79M $ - $ - -3.48 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.71M 3.20%

more financials information »

Passage Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PASG Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.072.26991.952.05595,8130.188.7%
1 Month2.252.4891.762.07297,1380.000.0%
3 Months1.892.8851.692.26459,0970.3619.05%
6 Months4.164.391.572.47436,305-1.91-45.91%
1 Year12.0212.421.574.99384,135-9.77-81.28%
3 Years22.2738.231.5712.34331,717-20.02-89.9%
5 Years22.2738.231.5712.34331,717-20.02-89.9%

Passage Bio Description

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Your Recent History
Passage Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now